New Alzheimer’s Drug Approved by UK Regulator
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved lecanemab, a new Alzheimer’s drug designed to slow cognitive decline in patients with the disease. This marks the first…
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved lecanemab, a new Alzheimer’s drug designed to slow cognitive decline in patients with the disease. This marks the first…
An experimental drug from Eli Lilly LLY.N works best if Alzheimer’s patients are treated as early as possible, ideally before they develop symptoms of the brain-wasting disease, researchers said on…